| Anticancer compounds |
2023-3-27 |
2023-5-10 |
|
| CHEMICAL COMPOUNDS |
2023-2-28 |
2023-5-05 |
|
| Process for preparing nucleoside prodrugs |
2023-1-20 |
2023-4-11 |
|
| Phosphoramidate derivatives of 5 - fluoro - 2' - deoxyuridine for use in the … |
2023-1-11 |
2023-6-01 |
|
| Salts of diphosphate phosphoramidate of nucleosides as anticancer compounds |
2022-12-16 |
2023-6-22 |
|
| Cancer treatment |
2022-11-18 |
2023-1-04 |
|
| Synthesis of phosphate derivatives |
2022-8-15 |
2022-12-22 |
|
| Cancer treatments based on gemcitabine prodrugs |
2022-8-08 |
2023-7-20 |
|
| Formulations of phosphoramidate derivatives of nucleoside drugs |
2022-8-02 |
2022-8-25 |
|
| Cancer treatments |
2022-8-01 |
2023-7-13 |
|
| Combination therapy |
2022-6-21 |
2023-5-18 |
|
| Combination therapy for cancer |
2022-6-20 |
2022-10-13 |
|
| Synthesis of diphosphate derivatives |
2022-6-14 |
2022-7-27 |
|
| 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine derivatives as … |
2022-6-06 |
2022-9-29 |
|
| Cancer treatment |
2022-5-12 |
2022-6-29 |
|
| Synthesis of nucleoside derivatives |
2022-4-01 |
2022-5-18 |
|
| Anticancer compounds |
2022-3-25 |
2022-5-11 |
|
| Antiviral therapy |
2022-2-23 |
2022-4-06 |
|
| Cytoprotection treatment |
2021-12-13 |
2022-1-26 |
|
| Formulation comprising gemcitabine-prodrug |
2021-10-28 |
2022-2-22 |
|
| Salt of triphosphate phosphoramidates of nucleotides as anticancer compounds |
2021-10-01 |
2022-1-27 |
|
| Synthesis of diphosphate derivatives |
2021-6-14 |
2021-7-28 |
|
| Salt |
2021-3-26 |
2021-5-12 |
|
| Anticancer compounds |
2021-3-26 |
2021-5-12 |
|
| Antiviral therapy |
2021-2-23 |
2021-4-07 |
|
| Phosphoramidate nucleoside derivatives as anticancer agents |
2021-1-06 |
2021-5-06 |
|
| Diastereoselective synthesis of phosphate derivatives |
2020-8-12 |
2021-1-14 |
|
| Gemcitabine prodrugs |
2020-8-11 |
2021-2-05 |
|
| Synthesis of diphosphate derivatives |
2020-6-12 |
2020-7-29 |
|
| Methods of separating gemcitabine-phosphate diastereoisomers |
2020-6-05 |
2021-7-22 |
2021-7-22 |
| Salt |
2020-3-27 |
2020-5-13 |
|
| Anticancer compounds |
2020-3-25 |
2020-5-06 |
|
| Antiviral therapy |
2020-3-05 |
2020-4-22 |
|
| Treatment regimens. |
2020-2-26 |
2020-9-25 |
|
| Synthesis of 8-chloroadenosine derivatives including nuc-9701 |
2019-12-18 |
2020-6-25 |
|
| Synthesis of diphosphate derivatives |
2019-6-12 |
2019-7-24 |
|
| Salt |
2019-3-26 |
2019-5-08 |
|
| Anticancer compounds |
2019-2-28 |
2019-4-17 |
|
| Adenosine derivatives for use in the treatment of cancer. |
2018-11-30 |
2019-5-10 |
|
| Crystalline form of gemcitabine |
2018-11-08 |
2019-8-02 |
|
| Floxuridine synthesis |
2018-9-18 |
2020-8-20 |
|
| Combination Therapy |
2018-8-30 |
2020-6-25 |
|
| Combination therapy. |
2018-6-22 |
2019-2-01 |
|
| Combination therapy. |
2018-4-03 |
2018-9-21 |
|
| Treatments for cancer |
2017-11-13 |
2018-7-06 |
|
| Formulations of phosphoramidate derivatives of nucleoside drugs |
2016-12-21 |
|
|
| Combination therapy |
2016-12-21 |
|
|
| POLYTHERAPY |
2016-12-21 |
2018-10-31 |
|
| Combination therapy |
2016-6-03 |
2016-7-20 |
|
| New 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine … |
2015-11-27 |
2021-5-27 |
|
| New 2' and/or 5' amino-acid ester phosphoramidate 3'-deoxy adenosine … |
2015-11-27 |
2022-6-28 |
|
| 2' AND/OR 5' DERIVATIVES 3-DEOXYADENOSINE AMINO ACID PHOSPHORAMIDATE ESTER, … |
2015-11-27 |
2023-7-18 |
|
| Chemical compounds |
2015-11-02 |
2015-12-16 |
|
| POLYTHERAPY |
2015-10-05 |
2018-8-15 |
|
| USE OF GENCITABINE-[PHENYL-BENZOXY-L-ALANYNYL)]-PHOSPHATE OR A PHARMACEUTICALLY … |
2015-10-05 |
2023-7-11 |
|
| Method for preparing gemcitabine [phenyl (benzyloxy L alaninyls)] phosphate |
2015-7-22 |
2017-5-31 |
|
| Formulation comprising a gemcitabine-prodrug |
2015-6-25 |
2021-5-27 |
|
| Chemical compounds |
2014-11-28 |
2015-1-14 |
|
| Formulations of phosphate derivatives |
2014-10-06 |
2014-11-19 |
|
| Prodrug |
2014-6-25 |
2014-8-06 |
|
| Replacement prosthesis |
2013-12-05 |
2014-6-05 |
|
| PHARMACEUTICAL COMPOSITION COMPRISING A RP/SP MIXTURE GEMCITABIN-[PHENYL- … |
2013-11-15 |
2023-5-30 |
|
| Phosphoramidate derivatives of nucleoside compounds for use in the treatment of … |
2013-5-07 |
2016-2-17 |
2016-2-17 |
| Derivados 2' e/ou 5' éster fosforamidato de aminoácido de 3- desoxiadenosina, … |
2015-11-27 |
2023-7-18 |
|
| Uso de gencitabina-[fenil-benzóxi-l-alaninil)]-fosfato ou um sal … |
2015-10-05 |
2023-7-11 |
|
| Composição farmacêutica compreendendo uma mistura de rp/sp gemcitabina-[fenil- … |
2013-11-15 |
2023-5-30 |
|